Sheridan Capital Partners Announces Majority Sale of DAS Health

Sheridan retains minority ownership as DAS enters its next chapter of growth

CHICAGO--(BUSINESS WIRE)--Sheridan Capital Partners (“Sheridan”) today announced the majority sale of DAS Health Ventures, LLC (“DAS Health” or “the Company”), a provider of healthcare IT and business solutions, to Coalesce Capital. Sheridan initially partnered with DAS Health in 2021 and will retain a minority ownership position following the transaction.

Founded in 2003 by David Schlaifer and headquartered in Tampa, FL, DAS Health provides managed IT services, cybersecurity, cloud hosting, revenue cycle management, compliance, and EHR/PM support to independent physician groups, hospitals, and senior living organizations across North America. Under Sheridan’s ownership, the Company expanded its geographic footprint—including entry into the Canadian market—broadened its service offerings, and completed four acquisitions, including vcpi, Itelagen, and Itentive, to strengthen its presence in the senior care and managed services segments. DAS also enhanced its leadership team, with Schlaifer transitioning to Executive Chairman and Michelle Jaeger appointed CEO in 2023.

“Sheridan has been an invaluable partner in helping DAS Health execute on our strategy,” said Michelle Jaeger, CEO of DAS Health. “Their support enabled us to broaden our capabilities and scale across the ambulatory and senior care markets. We are proud of what we’ve accomplished together and are excited to continue our momentum with Coalesce.”

“Since partnering with DAS Health in 2021, we have helped the company grow by over 400% by broadening its solutions and expanding its geographic reach and addressable market, thereby delivering more services to a greater number of growing clients across a broader spectrum of the healthcare landscape,” said Jonathan Lewis, Partner at Sheridan. “We are proud of the progress the DAS Health team has made and look forward to supporting their continued expansion alongside Coalesce Capital to deliver even more impact for healthcare organizations.”

Sheridan’s continued investment reflects its confidence in DAS Health’s long-term trajectory and the opportunities that remain ahead.

Houlihan Lokey served as financial advisor and McDermott, Will & Emery served as legal counsel to the Company.

The transaction was led by Jonathan Lewis, Chris McCrory, Sean Dempsey, and Jake Kohlbrenner at Sheridan Capital Partners. Terms of the transaction were not disclosed.

About DAS Health

DAS Health is a provider of healthcare IT and business solutions to independent and enterprise physician groups and healthcare systems across North America. Headquartered in Tampa, FL with regional offices in 15 US states and Canada, and an employee presence in 6 Canadian provinces and over 35 US states, DAS delivers managed IT services, cybersecurity, cloud hosting, revenue cycle management, value-based care, patient engagement, compliance, and practice management solutions impacting over 15 million patients nationwide. For more information on DAS Health, please visit www.dashealth.com.

About Sheridan Capital Partners

Sheridan Capital Partners is a Chicago-based healthcare private equity firm that focuses on lower middle market buyouts and growth equity in the U.S. and Canada. Sheridan partners with companies in the verticals of providers and provider services, healthcare IT and outsourced services, and consumer health and medical products, and strives to bring strategic resources to accelerate growth, build enduring value, and achieve strong results. For more information, please visit www.sheridancp.com/.